In the long effort to read the human genome completely and catch the mutations that drive cancer, a team at the University of Hong Kong has built an algorithm called ClairS that peers into the structurally complex regions where older tools go blind. Working with long-read sequencing technology, the system was trained not on scarce real cancer data, but on synthetic tumor-normal pairs conjured from healthy samples — a quiet methodological invention that may matter as much as the tool itself. Its integration into Oxford Nanopore's commercial workflow suggests this is no longer a laboratory curio